Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Iopamidol
Drug ID BADD_D01181
Description Iopamidol is a contrast agent developed by Bracco with nonionic, low-osmolar properties.
Indications and Usage Not Available
Marketing Status approved
ATC Code V08AB04
DrugBank ID DB08947
KEGG ID D01797
MeSH ID D007479
PubChem ID 65492
TTD Drug ID D0O2HQ
NDC Product Code 68225-077; 0270-1412; 68225-078; 68225-100; 0270-1315; 0270-1317; 0270-1411; 70436-126; 62331-006; 0270-1316; 68225-076; 0270-1314; 70436-124; 57876-222
UNII JR13W81H44
Synonyms Iopamidol | Jopamidol | Gastromiro | Iopamidol, (+-)-Isomer | Iopamidol, (R)-Isomer | Iopamidol, Sodium Salt, (S)-Isomer | Iopamiro | Isovue 370 | Niopam | Solutrast | Solutrast 370 | Solutrast Gastro | SQ 13,396 | B-15,000 | B 15,000 | B15,000 | B-15000 | B 15000 | B15000 | Isovue
Chemical Information
Molecular Formula C17H22I3N3O8
CAS Registry Number 60166-93-0
SMILES CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Retroperitoneal haemorrhage12.01.17.018; 24.07.01.017; 07.07.02.002--
Rhabdomyolysis15.05.05.0020.007113%
Rhinitis22.07.03.006; 11.01.13.004--
Sciatica17.10.03.001; 15.10.01.001--Not Available
Seizure17.12.03.0010.049794%
Sensory loss17.02.07.007--Not Available
Shock24.06.02.0020.007113%Not Available
Sinus arrest02.03.03.007--Not Available
Sinus bradycardia02.03.03.009--
Sinus congestion22.04.06.001--Not Available
Skin discolouration23.03.03.0050.031299%Not Available
Skin exfoliation23.03.07.003--Not Available
Skin necrosis23.03.03.011--Not Available
Skin reaction23.03.03.013; 10.01.03.019--Not Available
Skin warm23.03.03.0140.007113%Not Available
Sneezing22.12.03.0240.184237%
Speech disorder22.12.03.027; 19.19.02.002; 17.02.08.0030.007113%Not Available
Spinal cord injury17.10.04.001; 12.01.13.002--Not Available
Stupor19.02.05.004; 17.02.04.007--Not Available
Swelling08.01.03.0150.022763%Not Available
Swelling face08.01.03.100; 23.04.01.018; 10.01.05.0180.033433%Not Available
Swollen tongue10.01.05.015; 07.14.02.003; 23.04.01.0140.024897%Not Available
Syncope02.11.04.015; 24.06.02.012; 17.02.04.008--
Tachycardia02.03.02.007--Not Available
Tachypnoea22.02.01.0140.007113%Not Available
Throat irritation07.05.05.037; 22.12.03.0290.213402%Not Available
Throat tightness22.12.03.031; 19.01.02.0050.122350%Not Available
Thrombophlebitis24.01.02.001--Not Available
Tinnitus17.04.07.004; 04.04.01.002--
Tongue disorder07.14.01.002--Not Available
The 7th Page    First    Pre   7 8 9 10    Next   Last    Total 10 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene